This morning some companies may be in sharp focus among investors in light of the developments from yesterday, and one of the companies that could thus be in action is CB Scientific Inc. (OTC:CBSC). The company was in focus after it made an announcement with regards to a major product launch. In this feature, we will take a closer look.
The Product
The company announced yesterday that in collaboration with Datrix LLC, its contract manufacturer, it was on the verge of launching MyCardiaAT, an advanced cardiac event monitor. CB Scientific stated that the product had been aimed for use with its international distribution network across Southeast Asia, Macau, and Hong Kong. More importantly, the company announced that the product had also been approved by the United States Food and Drug Administration.
Further News
The product had been developed and designed to offer a better patient remote cardiac monitoring service. It was also easy to wear and lightweight, thereby making it easier to operate and transmitting the results to smartphones on both iOS and Android operating systems. In light of these developments, it would not be a surprise if investors interested in innovative healthcare companies take a shine towards CB Scientific.
